An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms
NACompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
September 30, 2004
Study Completion Date
September 30, 2005
Conditions
Chronic Schizophrenia
Interventions
DRUG
Galantamine
Trial Locations (1)
21228
Maryland Psychiatric Research Center, Catonsville
All Listed Sponsors
lead
University of Maryland, Baltimore
OTHER
NCT00161044 - An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms | Biotech Hunter | Biotech Hunter